The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT ID: NCT02512146
Last Updated: 2015-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2015-06-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase
NCT02566629
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629
Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBS
NCT03675100
Evaluation of Treatment Effect of Low FODMAP Diet in Treatment of IBS Patients
NCT05144204
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants may futher study the mechanism using cell experiment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Irritable bowel syndrome
Patients meeting Rome III criteria of irritable bowel syndrome. Intervention: colonoscopy.
colonoscopy
Patients will undergo colonoscopy and participants will get biopsies from the colon.
Normal controls
Asymptomatic individuals for health surveillance or patients for follow up after polypectomy.
Intervention: colonoscopy.
colonoscopy
Patients will undergo colonoscopy and participants will get biopsies from the colon.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
colonoscopy
Patients will undergo colonoscopy and participants will get biopsies from the colon.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanqing Li
Vice president of Qilu Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
xiuli zuo, PHD
Role: STUDY_DIRECTOR
Department of Gastroenterology, Qilu Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015SDU-QILU-G03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.